As a ferroptosis activator, RSL3 can cause the occurrence of cellular ferroptosis and idiopathic pulmonary fibrosis by directly inhibiting GPX4, which is associated with the redox imbalance in the lung. Here, GPX4 is linked to pulmonary fibrosis.